Similar Articles
Redefining multiple sclerosis: 2024 McDonald diagnostic criteria
Hazal Ceren Manazoğlu, Murat Kürtüncü
DOI: 10.55697/tnd.2025.500
Issue: 2025, Volume 31 - Issue 3
9544
7469
Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study
Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva
DOI: 10.55697/tnd.2025.494
Issue: 2025, Volume 31 - Issue 3
1516
932
Monocytes and systemic inflammation in Guillain-Barré syndrome: Subtypes and relationship with prognosis
Memet Aslanyavrusu, Fahrettin Ege, Gülhan Sarıçam
DOI: 10.55697/tnd.2025.508
Issue: 2025, Volume 31 - Issue 3
1170
881
Long-term cladribine experience in relapsing-remitting multiple sclerosis
Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç
DOI: 10.55697/tnd.2025.293
Issue: 2025, Volume 31 - Issue 3
1034
860
Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis
Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi
DOI: 10.55697/tnd.2025.323
Issue: 2025, Volume 31 - Issue 4
356
452
Audiovestibular findings according to the subtypes of multiple sclerosis
Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz
DOI: 10.55697/tnd.2025.442
Issue: 2025, Volume 31 - Issue 4
314
500
Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning
Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş
DOI: 10.55697/tnd.2025.511
Issue: 2025, Volume 31 - Issue 4
422
464
Antiquity, past, present, and future of in vivo diagnosis of Alzheimer’s disease
Hakan Gürvit
DOI: 10.55697/tnd.2025.533
Issue: 2025, Volume 31 - Issue 4
428
1523